Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol-Reference-Cited by-同舟云学术

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

Published:2002-07 Issue:4 Volume:53 Page:942-947
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Abitbol Andre,Abdel-Wahab May,Lewin Alan,Troner Michael,Rodrigues Maria-Amelia,Hamilton-Nelson Kara L,Markoe Arnold

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference33 articles.

1. Induction chemotherapy plus radiation in patients with advanced laryngeal cancer;N Engl J Med,1991

2. Larynx preservation in pyriform sinus cancer;Lefebvre;J Natl Cancer Inst,1996

3. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma;Calais;J Natl Cancer Inst,1999

4. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck;Merlano;J Natl Cancer Inst,1996

5. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer;Wendt;J Clin Oncol,1998

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Toxicities Associated with Concomitant Boost and Conventional Fractionated Radiotherapy Regimen in Oral and Oropharyngeal Cancers;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2017

2. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck;JAMA Otolaryngology–Head & Neck Surgery;2016-09-01

3. Concomitant boost chemoradiotherapy in locally advanced head and neck cancer: Treatment tolerance and acute side effects;Journal of Cancer Research and Therapeutics;2015

4. Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): A systematic review;Oral Oncology;2014-09

5. Prevention and management of treatment-induced pharyngo-oesophageal stricture;The Lancet Oncology;2013-08